Related Experiment Video
Updated: Jan 15, 2026
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Assessing the impact of unpublished data on network meta-analysis outcomes in outpatient adults with acute migraine:
A Dobrescu1, B Nussbaumer-Streit1, G Wagner1
1Cochrane Austria, Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Dr.-Karl-Dorrek-Strasse 30, Krems 3500, Austria.
Background And Objectives:
Methodological guidance recommends including both published and unpublished data in systematic reviews to enhance reliability and reduce potential bias. The objective of the study was to evaluate the impact of unpublished data from double-blind, pharmacologic randomized controlled trials on the results of network meta-analysis (NMA) of migraine treatments.
Methods:
We supplemented the search of a recent systematic review with targeted searches for unpublished data on ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform, regulatory agency reports, The Preprints Citation Index, Europe PubMed Central, and Embase.com, and conference abstracts from the past 5 years. Two independent reviewers selected eligible studies, verified publication status, extracted data, and reassessed certainty of evidence (COE). We reproduced the original NMA including unpublished data for four dichotomous outcomes. We compared our results with the original NMA in terms of risk ratio (RR), absolute risk difference with 95% CI, COE assessments, and conclusions.
Results:
Seventeen (6735 participants) of 37 eligible unpublished trials had posted results and were analyzed, with most (59%) identified via trial registries. In addition, unpublished outcome data were retrieved for four published trials from the original analysis. These unpublished trials added two previously unrepresented interventions to the NMA, increasing the number of direct comparisons and closed loops. Comparisons of RRs (95% CI) with the original analysis showed all effects maintained the same direction, although six CIs newly crossed the null effect (RR = 1). Among 144 COE assessments, four changed meaningfully: one was rated down from high to moderate due to imprecision, and three were rated up from very low/no evidence to low COE based on new direct evidence. Overall conclusions remained unchanged after including unpublished data.
Conclusions:
In this case study, adding unpublished data had minimal impact on results and conclusions, with only minor changes in network geometry and COE.
More Related Videos
05:49Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
Published on: November 1, 2024
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...